PD-1 EXPRESSION ON CLASSICAL MONOCYTES (CM) IS AN INDEPENDENT PREDICTOR OF CANCER SPECIFIC SURVIVAL IN CLEAR CELL RENAL CARCINOMA (CCRCC)

被引：0
|
作者：
Haseebuddin, Mohammed
MacFarlane, Alexander
Ruth, Karen
Uzzo, Robert
Plimack, Elizabeth
JIllab, Mowafaq
Dulaimi, Essel
Al-Saleem, Tahseen
Campbell, Kerry
Haseebuddin, Mohammed
机构：
来源：
JOURNAL OF UROLOGY | 2016年 / 195卷 / 04期
关键词：
D O I：
10.1016/j.juro.2016.02.2634
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP92-01
引用
收藏
页码：E1161 / E1161
页数：1
相关论文
共 50 条
  • [41] Pt1 conventional (clear cell) renal cell carcinoma: Associations with cancer-specific survival
    Cheville, JC
    Martin, SA
    Sebo, TJ
    Blute, ML
    Zincke, H
    Lohse, C
    Weaver, A
    MODERN PATHOLOGY, 2001, 14 (01) : 104A - 104A
  • [42] pT1 conventional (clear cell) renal cell carcinoma: Associations with cancer-specific survival
    Cheville, JC
    Martin, SA
    Sebo, TJ
    Blute, ML
    Zincke, H
    Lohse, C
    Weaver, A
    LABORATORY INVESTIGATION, 2001, 81 (01) : 104A - 104A
  • [43] Fibroblast growth factor receptor 1 (FGFR1) expression and activation in clear cell renal cell carcinoma (ccRCC).
    Ho, T. H.
    Wang, F.
    Hoang, A.
    Tamboli, P.
    Jonasch, E.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [44] PD-1/PD-L1 expression in chromophobe renal cell carcinoma: An immunological exception?
    Erlmeier, Franziska
    Hartmann, Arndt
    Autenrieth, Michael
    Wiedemann, Max
    Ivanyi, Philipp
    Steffens, Sandra
    Weichert, Wilko
    MEDICAL ONCOLOGY, 2016, 33 (11)
  • [45] PD-1/PD-L1 expression in chromophobe renal cell carcinoma: An immunological exception?
    Franziska Erlmeier
    Arndt Hartmann
    Michael Autenrieth
    Max Wiedemann
    Philipp Ivanyi
    Sandra Steffens
    Wilko Weichert
    Medical Oncology, 2016, 33
  • [46] Preoperative Butyrylcholinesterase Level as an Independent Predictor of Overall Survival in Clear Cell Renal Cell Carcinoma Patients Treated with Nephrectomy
    Koie, Takuya
    Ohyama, Chikara
    Mikami, Jotaro
    Iwamura, Hiromichi
    Fujita, Naoki
    Sato, Tendo
    Kojima, Yuta
    Fukushi, Ken
    Yamamoto, Hayato
    Imai, Atsushi
    Hatakeyama, Shingo
    Yoneyama, Takahiro
    Hashimoto, Yasuhiro
    Kitayama, Masato
    Hirota, Kazuyoshi
    SCIENTIFIC WORLD JOURNAL, 2014,
  • [47] New Preoperative Inflammatory Score Is an Independent and Significant Predictor of Overall Survival in Localized Clear Cell Renal Cell Carcinoma
    Melnick, Kevin R.
    Khan, Amir I.
    Patil, Dattatraya
    Kim, Frances
    Patel, Amar P.
    Bilen, Mehmet A.
    Kucuk, Omer
    Filson, Christopher P.
    Ogan, Kenneth
    Master, Viraj
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2018, 227 (04) : E244 - E244
  • [48] Microvascular invasion is associated with aggressive clinicopathological features and is an independent predictor of survival for patients with clear cell renal cell carcinoma
    Lam, JS
    Seiler, D
    Leppert, JT
    Pantuck, AJ
    Thomas, GV
    Said, JW
    Figlin, RA
    Belldegrun, AS
    JOURNAL OF UROLOGY, 2006, 175 (04): : 241 - 241
  • [49] The Clinical Activity of PD-1/PD-L1 Inhibitors in Metastatic Non-Clear Cell Renal Cell Carcinoma
    McKay, Rana R.
    Bosse, Dominick
    Xie, Wanling
    Wankowicz, Stephanie A. M.
    Flaifel, Abdallah
    Brandao, Raphael
    Lalani, Aly-Khan A.
    Martini, Dylan J.
    Wei, Xiao X.
    Braun, David A.
    Van Allen, Eliezer
    Castellano, Daniel
    De Velasco, Guillermo
    Wells, J. Connor
    Heng, Daniel Y.
    Fay, Andre P.
    Schutz, Fabio A.
    Hsu, JoAnn
    Pal, Sumanta K.
    Lee, Jae Lyun
    Hsieh, James J.
    Harshman, Lauren C.
    Signoretti, Sabina
    Motzer, Robert J.
    Feldman, Darren
    Choueiri, Toni K.
    CANCER IMMUNOLOGY RESEARCH, 2018, 6 (07) : 758 - 765
  • [50] A Critical Insight into the Clinical Translation of PD-1/PD-L1 Blockade Therapy in Clear Cell Renal Cell Carcinoma
    Nunes-Xavier, Caroline E.
    Angulo, Javier C.
    Pulido, Rafael
    Lopez, Jose I.
    CURRENT UROLOGY REPORTS, 2019, 20 (01)
12345